This webinar will provide advice on how to set your small company up for long-term success through the use of strategic development plans, purposeful outsourcing, patent protection, partnership strategies, and provide specific examples of success stories and lessons learned. Register now!
Learn practical strategies for implementing patient-centered principles that engage patients without sacrificing research quality or adding untenable costs to your trials. During this webinar, experts will share how to design trials that honor patient needs and desires. Register Now!
Transformation initiatives underway for Regulatory Information Management. Pharma is taking a more holistic approach to managing regulatory processes. Read how their efforts are paying off.
The largest survey of TMF owners reveals drivers and trends in improving inspection readiness and shortening trial time. Read more.
There are many reasons companies initiate process harmonization efforts: mergers and acquisitions, globalization, or the adoption of new technologies.
This paper provides a dozen best practices for designing global systems that will help make process harmonization initiatives successful. Read it now.
FiercePharma's Eric Palmer and FierceBiotech's Damian Garde discuss the confirmation of Robert Califf as the next FDA commissioner, Sanofi's efforts to undercut Novo Nordisk in diabetes, and a novel approach to regulating drug costs. Download the episode on iTunes or Stitcher, or listen here--and be sure to subscribe.
FiercePharma's Eric Palmer and FierceBiotech's Damian Garde discuss a bizarre congressional hearing, how biotech's slump affects the buyout climate, and a major development in the world of biosimilars.
FiercePharma's Eric Palmer and FierceBiotech's Damian Garde discuss the future of Gilead Sciences, biotech's continued slump on Wall Street, and the latest move in Sanofi's efforts to right the ship.